References with Amyloid Beta Peptides
Publications
- Analyzing Microglial‑Associated Aβ in Alzheimer’s Disease Transgenic Mice With a Novel Mid‑Domain Aβ‑Antibody
- In Situ Structural Characterization of Early Amyloid Aggregates in Alzheimer’s Disease Transgenic Mice And Octodon Degus
- Misfolded Amyloid-β-42 Impairs The Endosomal–Lysosomal Pathway
- Method For Detecting Aggregate Of Aggregate - Forming Polypeptidemethod For Detecting Aggregate Of Aggregate - Forming Polypeptide
- Novel D - Enantiomeric Peptides Derived From D3 And Use Thereof
- Poly(propylene imine) Dendrimers With Histidine-Maltose Shell as Novel Type of Nanoparticles for Synapse and Memory Protection
- The Metalloprotease ADAMTS4 Generates N-truncated Aβ4–x Species and Marks Oligodendrocytes as a Source of Amyloidogenic Peptides in Alzheimer’s Disease
- Amyloid-Peptide β 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-Terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4.
- A Peptide or Collection of Peptides Derived from Amyloid Precursor Protein
- Synchrotron-Based µFTIR Study on the Effect of Alzheimer´s Aβ Amorphous and Fibrillar Aggregates on PC12 Cells
- High Affinity Binding of Monomeric, but not Oligomeric Amyloid-β to Ganglioside GM1 Containing Nanodiscs
- Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice
- A Critical Role For the Self-Assembly of Amyloid-β1-42 in Neurodegeneration
- Characterization of Insulin-Degrading Enzyme-Mediated Cleavage of Aβ in Distinct Aggregation States
- Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
- Assessment of Structural Properties of Amyloid Aggregates and Their Application Potential
- Inhibition of the Cardiac Na+ Channel α-Subunit Nav1. 5 by Propofol and Dexmedetomidine
- Aβ-42 Lowering Agents From the Marine-Derived Fungus Dichotomomyces Cejpii
- η-Secretase Processing of APP Inhibits Neuronal Activity in the Hippocampus
- Hybridization of an Aβ-Specific Antibody Fragment with Aminopyrazole-Based β Sheet Ligands Displays Striking Enhancement of Target Affinity
Archive
- Neprilysin Deficiency Alters the Neuropathological and Behavioral Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease
- Monoclonal Antibodies Against Ab42 Fibrils Distinguish Multiple Aggregation State Polymorphisms in vitro and in Alzheimer's Disease Brain
- The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-β (Aβ) Aggregation
- Structure and Biomedical Applications of Amyloid Oligomer Nanoparticles
- Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4
- The D-Amino Acid Peptide D3 Reduces Amyloid Fibril Boosted HIV-1 Infectivity
- Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer’s Disease?
- Effect of Poly(propylene imine) Glycodendrimers on β-Amyloid Aggregation in Vitro and in APP/PS1 Transgenic Mice, as a Model of Brain Amyloid Deposition and Alzheimer’s Disease
- Nanoparticulate Flurbiprofen Reduces Amyloid-β42 Generation in an in Vitro Blood-Brain Barrier Model
- The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
- Exploring the Sequence–Structure Relationship for Amyloid Peptides
- Analysis of Quality, Aggregation and Toxicity of Amyloid Beta Peptide Produced by JPT
- Active Immunization with Amyloid-β 1–42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System
- Mechanism of Amyloid Plaque Formation Suggests an Intracellular Basis of Aβ Pathogenicity
- Novel Mediators of Amyloid Precursor Protein Signaling
- DNA Beta-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
- Vaccination with Prion Peptide-Displaying Papillomavirus-like Particles Induces Autoantibodies to Normal Prion Protein that Interfere with Pathologic Prion Protein Production in Infected Cells
- In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
All Our Publications
- References with PepMaster™
- References with PepMix™ Peptide Pools - Control Pools
- References with PepMix™ Peptide Pools - Infectious Diseases
- References with PepMix™ Peptide Pools - Tumor Associated Antigens
- References with Clinical Peptides
- References with PepStar™ & RepliTope™ Peptide Microarrays
- References with Peptide ELISA
- References with Reference Peptides for Targeted Proteomics - SpikeTides™ & SpikeMix™
- References with Absolute Quantified Peptides - SpikeTides™ TQL & SpikeTides™ TQL PLUS
- References with PepTrack™ Peptide Libraries
- References with Custom Peptide Synthesis
- References with Specialty Peptides
- References with Conjugates
- References with SpotMix™
- References with PepSpots™ Peptides on Cellulose
- References with Amyloid Beta Peptides
- References with Antigen Peptides
- References with Micro-Scale Peptide Sets
- References with BioTides™ Biotinylated Peptides
- References with ProteaseSpots™
- References with Histone Code Tools
- References with Enzyme Substrate Microarrays
- References with Enzyme Profiling - Assay Service
- References with Enzyme Substrate Sets
- References with Protein Interaction Screen on Peptide Matrix (PRISMA)
- References with Microarray Accessories
- References with Bioinformatics: Library Design, Data Mining & Evaluation
- References with Computational Chemistry: Molecular Design and Lead Optimization
- References with MHC Multimers
